Matthew Gunn

Matthew Gunn

Director Director DIN 03552729
DIN 03552729 First appointment Jul 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Matthew Gunn

Data last updated:

Matthew Gunn was a Director at Ppd Pharmaceutical Development India Private Limited (2011–2020) and Director at Vigi Medsafe Private Limited (from 2019). The companies operate in Pharma.

DIN 03552729
Primary Designation Director
Industry Pharma
First Appointment 11 Jul 2011
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jul 20112004₹458 Cr (FY 2025)Active
Vigi Medsafe Private Limited U85110MH2013PTC335392
Director24 Jan 20192013₹13.91 Cr (FY 2019)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vigi Medsafe Private Limited
Ppd Pharmaceutical Development India Private Limited
Premium access

Shareholding and investment profile for Matthew Gunn

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Matthew Gunn

Matthew Gunn was first appointed on 11 Jul 2011 as Director at Ppd Pharmaceutical Development India Private Limited. The most recent appointment on record is 24 Jan 2019 at Vigi Medsafe Private Limited.

Matthew Gunn held 2 earlier board appointments: Ppd Pharmaceutical Development India Private Limited (Director, 11 Jul 2011 to 19 Aug 2020); Vigi Medsafe Private Limited (Director, from 24 Jan 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available